Skip to main content

Table 2 Summary of self-reported comfort scores rated on a 10-point VAS at 48 h post-treatment comparing treatment (Floseal® (Baxter, USA)) to control (traditional packing methods)

From: Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial

Pain

Treatment (Floseal) (N = 13)

Control (N = 13)

Z-score

p-valuea

Placement

2.4

7.8

3.6987

0.0022

Treatment

0.5

4.5

3.3800

0.0007

Removal

0

3.9

3.0699

0.0021

  1. a α = 0.05, significant results in bold using unpaired Mann-Whitney U test; mean 10-pt VAS of patient pain experienced (0 = no pain, 10 = worst pain ever experienced)